StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Cardiol Therapeutics Inc.
Toronto Stock Exchange:CRDL.TO
Sector
Industries
Location
Market Cap
USD 105.96 M
Share Price
USD 1.17
Avg Daily Volume
74,290
Change (1 day)
0.21%
Change (1 year)
-40.66%
Change (YTD)
-8.78%
Cardiol Therapeutics Inc. Operating Income for the year ending December 31, 2024: USD -27.99 M
Cardiol Therapeutics Inc. Operating Income is USD -27.99 M for the year ending December 31, 2024, a 24.54% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
-
Cardiol Therapeutics Inc. Operating Income for the year ending December 31, 2023 was USD -22.47 M, a -39.48% change year over year.
-
Cardiol Therapeutics Inc. Operating Income for the year ending December 31, 2022 was USD -37.14 M, a 3.29% change year over year.
-
Cardiol Therapeutics Inc. Operating Income for the year ending December 31, 2021 was USD -35.95 M, a 122.30% change year over year.
-
Cardiol Therapeutics Inc. Operating Income for the year ending December 31, 2020 was USD -16.17 M, a 54.74% change year over year.
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Medtronic plc
USD 89.61
MDT
+0.08
0.09%
RELX Plc
USD 53.04
REL.L
-0.48
-0.90%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
CSL Limited
USD 167.39
CSL.AX
+6.23
3.87%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
Key Data
| Date | Operating Income | EBIT | EBITDA | Net Income |
|---|
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Medtronic plc
USD 89.61
MDT
+0.08
0.09%
RELX Plc
USD 53.04
REL.L
-0.48
-0.90%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
CSL Limited
USD 167.39
CSL.AX
+6.23
3.87%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%